- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02557698
Effectiveness of Using an Oil Bath Additive
Prospective, Randomized Study on the Skin Functional Parameters to Assess Skin Barrier Improvement After the Use of a Commercially Available Oil Bath Containing 84.75% Soybean Oil Compared to no Bath Additive
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 10117
- Charite - Universitatsmedizin Berlin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed informed consent, or children whose parent(s) or guardian(s) have given their written informed consent for their child's participation in the study
- Child specific written informed consent, if over 7 years of age
- Subjects with a general good and stable health condition
- Subjects with clinically stable medical conditions
- Accept to abstain from sunbathing and solarium during the study
- Overall Dry Skin score (ODS) of 1 to 2 at arms and lower legs
- TEWL > 12 g/m2/h on the left mid volar forearm
Exclusion Criteria:
- Any dermatological condition or skin affection which may interfere with the study assessments, e.g. scars
- Suffering from porphyria
- Suffering from severe photodermatoses according to the judgment of the investigator
- Clinically significant, possibly unstable medical conditions such as metastatic tumor
- Currently having other malignant or benign tumors of the skin in the investigational area
- Any other acute or chronic pathology that may interfere with the study conduct in the investigator's opinion
- Known allergy or intolerance to any ingredients of the study product, e.g. propylene glycol
- Use of (medical) oil-containing bath additives or other oil-containing cleansers
- Current topical or systemic treatment affecting the skin, e.g. diuretics
- Treatment of dry and/or inflammatory skin conditions with topical corticosteroids during the 4 weeks before inclusion
- Systemic immunosuppressive or immunomodulatory therapy
- Topical retinoids applied during the 6 weeks before inclusion
- Topical application of immunosuppressive treatment during the 6 weeks before inclusion
- Therapeutic UV-Radiation during the 6 weeks before inclusion
- Increased UV-exposure during the 6 weeks before inclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balneum oil bath
Balneum oil bath, bathing every other day for four weeks
|
|
|
No Intervention: standard skin cleanser
Usual skin cleanser (non-oil containing), bathing or showering every other day for four weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
Time Frame: Day 28 +/- 3
|
TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h on the left midvolar forearm. Visit 3 (day 28) - end of study visit |
Day 28 +/- 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
Time Frame: Day 14 +/- 2
|
TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h on the left midvolar forearm. Visit 2 (day14) - intermediate visit |
Day 14 +/- 2
|
|
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
|
TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h at the right lateral lower leg. Visit 2 (day14) |
Day 14 +/- 2
|
|
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
|
TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h at the right lateral lower leg. Visit 3 (day 28) |
Day 28 +/- 3
|
|
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
|
SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out. Visit 2 (day 14) |
Day 14 +/- 2
|
|
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
|
SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher is SCH. Per investigational site three replicate measurements were carried out. Visit 3 (day 28) |
Day 28 +/- 3
|
|
Skin Surface Mean Roughness (Ra) in µm at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany).
It consists of a UV light camera and measures the skin surface profiles.
Ra=mean roughness
|
Day 14 +/- 2
|
|
Skin Surface Mean Roughness (Ra) in µm at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany).
It consists of a UV light camera and measures the skin surface profiles.
Ra=mean roughness
|
Day 28 +/- 3
|
|
Skin Surface Mean Roughness (Rz) in µm at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device.
It consists of a UV light camera and measures the skin surface profiles.
The parameter Rz was calculated.
Rz=mean roughness of five equally spaced sampling lenghts.
|
Day 14 +/- 2
|
|
Skin Surface Mean Roughness (Rz) in µm at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device.
It consists of a UV light camera and measures the skin surface profiles.
The parameter Rz was calculated.
Rz=mean roughness of five equally spaced sampling lenghts.
|
Day 28 +/- 3
|
|
Skin Surface pH at the Right Lateral Lower Leg
Time Frame: Day 14 +/- 2
|
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003).
The pH of the skin surface may differ from the pH of the stratum corneum.
Means of triple measurements/images per skin area.
|
Day 14 +/- 2
|
|
Skin Surface pH at the Right Lateral Lower Leg
Time Frame: Day 28 +/- 3
|
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003).
The pH of the skin surface may differ from the pH of the stratum corneum.
Means of triple measurements/images per skin area.
|
Day 28 +/- 3
|
|
Overall Dry Skin (ODS) Score at the Left Arm
Time Frame: Day 14 +/- 2
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day14) - intermediate visit |
Day 14 +/- 2
|
|
Overall Dry Skin (ODS) Score at the Left Arm
Time Frame: Day 28 +/- 3
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness by the investigator using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) |
Day 28 +/- 3
|
|
Overall Dry Skin (ODS) Score at the Right Arm
Time Frame: Day 14 +/- 2
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day14) |
Day 14 +/- 2
|
|
Overall Dry Skin (ODS) Score at the Right Arm
Time Frame: Day 28 +/- 3
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) |
Day 28 +/- 3
|
|
Overall Dry Skin (ODS) Score at the Left Lower Leg
Time Frame: Day 14 +/- 2
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14) - intermediate visit |
Day 14 +/- 2
|
|
Overall Dry Skin (ODS) Score at the Left Lower Leg
Time Frame: Day 28 +/- 3
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) - end of study visit |
Day 28 +/- 3
|
|
Overall Dry Skin (ODS) Score at the Right Lower Leg
Time Frame: Day 14 +/- 2
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14) - intermediate visit |
Day 14 +/- 2
|
|
Overall Dry Skin (ODS) Score at the Right Lower Leg
Time Frame: Day 28 +/- 3
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) |
Day 28 +/- 3
|
|
Overall Dry Skin (ODS) Score at the Trunk
Time Frame: Day 14 +/- 2
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 2 (day 14) |
Day 14 +/- 2
|
|
Overall Dry Skin (ODS) Score at the Trunk
Time Frame: Day 28 +/- 3
|
The Overall Dry Skin score is a standardized instrument to clinically assess the presence or severity of skin dryness using a five point rating scale according to Serup1995, Kang et al. 2014 on both arms, lower legs and trunk. (0=Absent, 1=Faint scaling, faint roughness and dull appearance, 2=Small scales in combination with a few larger scales, slight roughness and whitish appearance, 3=Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4=Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks) Visit 3 (day 28) - end of study visit |
Day 28 +/- 3
|
|
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
|
SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out. Visit 2 (day 14) |
Day 14 +/- 2
|
|
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
|
SCH was measured using the Corneometer (Courage+Khazaka, Cologne, Germany) according to international guidelines which measured the hydratation level of the stratum corneum as electrical capacitance (Berardesca et al. 1997). The higher the values, the higher the SCH. Per investigational site three replicate measurements were carried out. Visit 3 (day 28) |
Day 28 +/- 3
|
|
Skin Surface Mean Roughness (Ra) in µm at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany).
It consists of a UV light camera and measures the skin surface profiles.
Ra=mean roughness
|
Day 14 +/- 2
|
|
Skin Surface Mean Roughness (Ra) in µm at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany).
It consists of a UV light camera and measures the skin surface profiles.
Ra=mean roughness
|
Day 28 +/- 3
|
|
Skin Surface Mean Roughness (Rz) in µm at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device.
It consists of a UV light camera and measures the skin surface profiles.
The parameter Rz was calculated.
Rz=mean roughness of five equally spaced sampling lenghts.
|
Day 14 +/- 2
|
|
Skin Surface Mean Roughness (Rz) in µm at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
|
Skin roughness was measured using the Visioscan VC98 (Courage+Khazaka, Cologne, Germany) device.
It consists of a UV light camera and measures the skin surface profiles.
The parameter Rz was calculated.
Rz=mean roughness of five equally spaced sampling lenghts.
|
Day 28 +/- 3
|
|
Skin Surface pH at the Left Midvolar Forearm
Time Frame: Day 14 +/- 2
|
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003).
The pH on the skin surface may differ from the pH of the stratum corneum.
Means of triple measurements/images per skin area.
|
Day 14 +/- 2
|
|
Skin Surface pH at the Left Midvolar Forearm
Time Frame: Day 28 +/- 3
|
Skin surface pH was measured using the Skin-pH-Meter PH905 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Parra et al. 2003).
The pH on the skin surface may differ from the pH of the stratum corneum.
Means of triple measurements/images per skin area.
|
Day 28 +/- 3
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CRC-SP-ABC-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerosis Cutis
-
Shyla CantorSytheon Ltd.CompletedXerosis CutisUnited States
-
Indonesia UniversityCompletedXerosis CutisIndonesia
-
PD Dr. Jan KottnerCompleted
-
Universitas Syiah KualaCompletedXerosis Cutis | Dry SkinIndonesia
-
Indonesia UniversityCompleted
-
University of ArizonaUniversity of California, DavisCompletedXerosis Cutis | Xerosis | Dry Skin; EczemaUnited States
-
Societa Italiana di Dermatologia Medica, Chirurgica...Recruiting
-
Galderma R&DCompleted
-
Indonesia UniversityUnknownDiabetes Mellitus, Type 2 | Xerosis CutisIndonesia
-
Hoth Therapeutics, Inc.ICON Clinical ResearchRecruitingAcneiform Eruption Due to Chemical | Xerosis Cutis | ParonychiaUnited States, Poland, Spain
Clinical Trials on Balneum oil bath
-
Oslo University HospitalUniversity of Oslo; Norwegian Institute of Public Health; Karolinska Institutet; Helsinki University Central Hospital and other collaboratorsActive, not recruitingObesity | Cardiovascular Disease | Asthma | Rhinitis, Allergic | Atopic Dermatitis | Food Allergy in Children | Non-communicable DiseasesNorway
-
Istanbul University - CerrahpasaCompletedInfant BehaviorTurkey
-
Paracelsus Harz Clinic Bad Suderode.Completed
-
Afyonkarahisar Health Sciences UniversityRecruitingComplex Regional Pain Syndrome | Distal Radius Fracture | Complex Regional Pain Syndrome Type ITurkey
-
The Affiliated Hospital of Putian UniversityNot yet recruiting
-
Nuh Naci Yazgan UniversityTC Erciyes UniversityCompletedVital | Blood Gases
-
Schweinhardt PetraRecruitingLow Back Pain | Compare Pain Modulation Assessments in Pain-free CohortsSwitzerland
-
Marmara UniversityNot yet recruiting
-
Hacettepe UniversityCompletedRheumatoid Arthritis - RheumatismTurkey
-
Providence CollegeRecruitingElevated Blood PressureUnited States